The board of directors of pharmaceutical company Eli Lilly and Company (NYSE:LLY) on Monday declared a dividend of USD1.50 per share of common stock for the second quarter of 2025.
This amount is unchanged from the first quarter.
Shareholders of record at the close of business on 16 May 2025 will receive the dividend on 10 June 2025.
Genomma Lab Internacional announces Q2 2025 results
Sanofi finalizes acquisition of Blueprint Medicines to expand rare disease and immunology portfolio
Perrigo to divest Dermacosmetics business for up to EUR327m
Bavarian Nordic sells US Priority Review Voucher for USD160m
Bavarian Nordic sells US Priority Review Voucher for USD160m
FDA grants priority review to Innoviva's zoliflodacin for treatment of gonorrhea
Sanofi to acquire Blueprint Medicines in USD9.5bn rare disease deal
Eisai forecasts 73% Leqembi revenue growth in FY 2025, boosting BioArctic royalties